Utilization of traditional medicines increased worldwide. However, lack of modern technology creates problems for rejection of such preparations. Good manufacturing practices (GMPs) advocate uniformity and stability in the development of modern pharmaceuticals. Implementation of appropriate formulation strategies may enhance regulatory acceptance of complementary medicines. Herewith an attempt has been made to identify the impact of process parameter temperature, pH, and yeast cell number (inoculum volume) on manufacturing of ayurvedic fermented cardiotonicâ€”arjunarishta.